Kevin Koch
President and CEO at Edgewise Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Edgewise Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Edgewise Therapeutics Inc. June 7, 202491.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Edgewise Therapeutics Inc. | Option exercise | +17,969 | — | — |
| Aug 12, 2026 | Edgewise Therapeutics Inc. | Option exercise | +21,875 | — | — |
| Aug 12, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −8,782 | $43.64 | $383,246 |
| Aug 12, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −8,276 | $43.66 | $361,330 |
| Aug 12, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −913 | $44.33 | $40,473 |
| Aug 12, 2025 | Edgewise Therapeutics Inc. | Option exercise | +17,968 | — | — |
| Aug 12, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −7,972 | $13.39 | $106,745 |
| May 2, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −4,276 | $16.45 | $70,340 |
| May 1, 2025 | Edgewise Therapeutics Inc. | Option exercise | +10,417 | — | — |
| Mar 7, 2025 | Edgewise Therapeutics Inc. | Option exercise | +100 | $0.18 | $18 |
| Mar 7, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −100 | $30.00 | $3,000 |
| Feb 6, 2025 | Edgewise Therapeutics Inc. | Option exercise | +900 | $13.11 | $11,799 |
| Feb 6, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −900 | $31.13 | $28,017 |
| Feb 5, 2025 | Edgewise Therapeutics Inc. | Option exercise | +8,636 | $0.18 | $1,554 |
| Feb 5, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −8,636 | $30.03 | $259,339 |
Questions about Kevin Koch
What boards is Kevin Koch on?
Kevin Koch sits on the board of Edgewise Therapeutics Inc.
What company is Kevin Koch the CEO of?
Kevin Koch is President and CEO of Edgewise Therapeutics Inc.
How long has Kevin Koch served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.